Portfolio Company News 06/09/2008 Targanta submits Marketing Authorization Application for Oritavancin 05/20/2008 Targanta Completes Enrollment in Phase 2 Oritavancin Infrequent Dosing Study 04/17/2008 Coserics Announces Company Formation Including Spin-Out of Phase 2 Clinical Asset From Serenex 04/09/2008 Targanta Announces FDA Acceptance of Oritavancin New Drug Application 03/24/2008 Targanta Reports Fourth-Quarter and Full-Year 2007 Financial Results 03/03/2008 Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform 02/27/2008 SERENEX ANNOUNCES COLLABORATION WITH NATIONAL CANCER INSTITUTE TO INITIATE CLINICAL TRIAL WITH SERENEX’S PROPRIETARY SMALL MOLECULE HSP90 INHIBITOR, SNX-5422 12/04/2007 SERENEX ANNOUNCES INITIATION OF SECOND PHASE 1 TRIAL FOR ORAL HSP90 INHIBITOR, SNX-5422 11/15/2007 Targanta Reports Third-Quarter 2007 Financial Results 10/10/2007 Targanta Therapeutics announces pricing of its Initial Public Offering 09/20/2007 Zelos Osteoporosis Drug Generates Strong Clinical Results 09/19/2007 Zelos Therapeutics Presents Positive Data at ASBMR on Subcutaneous and Inhaled Delivery of Cyclic PTH (1-31) (Ostabolin-C™) 09/13/2007 Targanta initiates Phase 2 Oritavancin Infrequent Dosing Study 06/28/2007 Serenex Secures $31 Million in Financing 05/31/2007 Serenex Announces Initiation of Phase 1 Trial for Oral Hsp90 Inhibitor, SNX-5422 05/14/2007 Targanta Therapeutics Files IPO For $86.25M In Common Stock 05/10/2007 Hansen Medical Launches Sensei Robotic Catheter System and Artisan Control Catheter at Heart Rhythm Society's Scientific Sessions 05/03/2007 Hansen Medical shares soar after catheter system gets OK 02/12/2007 Targanta Closes $70M Series C For Product Launch 02/09/2007 Targanta Announces $70 Million Series C Financing 02/09/2007 From soil in Haiti, hopes for antibiotic 02/08/2007 Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial 12/22/2006 Hansen Medical Announces Successful Completion of Clinical Trial For Sensei Robotic Catheter System 11/16/2006 Hansen Medical Announces Initial Public Offering 07/12/2006 SERENEX ANNOUNCES THE START OF A PHASE 2 CLINICAL TRIAL OF SNX-1012 FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED ORAL MUCOSITIS 04/19/2006 OCRI awards outstanding contributions to the Ottawa region 02/07/2006 Zelos Therapeutics Completes Enrollment in Two Ostabolin-C™ Phase 2 Clinical Trials 01/17/2006 United BioSource Acquires MetaWorks, Inc. 10/06/2005 Serenex Raises $30 Million in Series C Financing 05/18/2005 Zelos Therapeutics Raises $42.5 Million Financing Company Reports Progress for Two Clinical Programs 01/27/2005 ViaCell, Inc. (VIAC) Completes Initial Public Offering; Sells All Over-Allotment Shares 10/05/2004 Zelos Therapeutics Tops Off Series-A Financing With CDN $7 Million 09/23/2004 Sopherion Therapeutics Raises $47M in Series B Funding and Acquires North American Rights to Myocet® Launch Planned for Second Quarter of 2005 in Canada 09/23/2004 Sopherion ZENEUS PHARMA LIMITED CANCER DRUG OUTLICENSED TO SOPHERION THERAPEUTICS INC. US FIRST FOR ZENEUS PHARMA   View the Archives